Category Archives

One Article

Posted by frammin on

“Chairman of Renovia Inc. Marc Beer “

Marc beer is the co-founder of Renovia group in August 2016 together with Lorie Yolanda. The company is located in Boston. Beer is also the former Aegerion CEO. He has more than 25 years of growth and commercialization knowledge in biotechnology, diagnostics, pharmacy, and devices. He studied his business degree at Miami University Ohio where he is a member of Miami University Business Advisory Council and also was a member of the Notre Dame Graduate Studies Research AND advisory Council.


He was also served as Viacell CEO a biotechnology company dealing with the collection, conservation, and growth of umbilical cord blood stems cells. The company went public in 2005 and was taken by PerkinElmer in 2007. Marc led the company for seven years from its start-up to a swiftly growing and stout commercial company.


Beer also served as a member of the board of directors of Erytech Pharma a biopharmaceutical organization, Mass life science board of the Commonwealth of Massachusetts and as well as the Biotechnology Industry organization Emerging Company Section among a host of many other boards. Presently he’s the chairman of Good start Genetics Compensation committee.


He raised 42 million dollars for women health products. The company is addressing pelvic floor disorders. The company is creating various analytical and curative products to take care of pelvic floor disorders. The disorders include for example urinary incontinence. Research indicates that at least 250 million women in the whole world are affected. Leva is Renovia first merchandise which was approved by the FDA in April 2018


Renovia has received funding also from the Longwood fund. The medical care firm was led by Ascension ventures from Missouri and Perceptive Advisors from New York. The support will help develop and analyze four more curative and diagnostic merchandise among them a new creation of the Leva product. This will be greatly achieved by combining innovative and aptness sensor technologies. It will also provide the customer with precious information about the new healing options and convey knowledge on pelvic floor disorder leading to a reduction in treating cost and the reduction of women who are affected. Learn more: